In a survey, 42% of trimethoprim-resistant clinical members of the family Enterobacteriaceae were able to transfer trimethoprim resistance to standard Escherichia coli strains when selection was made on complex bacteriological media. When transfer experiments were performed with minimal medium, another 16% of the clinical strains were shown to have transferred trimethoprim resistance. Twelve transconjugants produced negligible trimethoprim resistance in complex media but were resistant in minimal medium. The methionine, glycine, and purine components of complex media appeared to be responsible for the reduced expression of trimethoprim resistance in these strains.
Bacterial resistance to trimethoprim, defined as the ability of organisms to grow in trimethoprim concentrations of 10 mg/liter or more, has increased gradually since the introduction of this drug, in combination with sulfamethoxazole, in 1969 (see reference 13 for a review). Resistance plasmids (R plasmids) conferring resistance to trimethoprim (Tpr) were first described by Fleming et al. (9) . These plasmids, isolated from strains of Escherichia coli and Klebsiella spp., conferred a characteristically high level of Tpr on their hosts (MIC >1,000 mg/liter). In subsequent years there have been many reports of transferable Tpr (1, 2, 12, 15, 19) . In addition, two recent reports of R plasmids conferring only moderate levels of Tpr (MIC = 64 to 256 mg/liter) have appeared (10, 21) . In almost all cases, the identification of trimethoprim R plasmids has depended on the ability to detect Tpr transconjugant strains on suitable complex media after the incubation of donors with suitable recipients. In addition, similar media have usually been used to determine the level of resistance conferred by the plasmids (7, 10, 20, 21) .
In a recent survey in South India, we found the incidence of trimethoprim resistance among gram-negative urinary pathogens was 64% (22) . In the present paper we describe the methods which detected trimethoprim R plasmids from these resistant bacteria and which allowed the identification of a new type of trimethoprim R plasmid.
MATERIALS AND METHODS
Bacteria and plasmids. Clinical strains of members of the family Enterobaciteriaceae were isolated in a recent study of urinary pathogens from patients at the Christian Medical College Hospital in Vellore, South India. E. coli K-12 J62 pro-his-try-, resistant to either rifampin (J62-2) or nalidixic acid (J62-1), was used as the recipient in transfer experiments (5) . The transfer factor X+ (16) was used for the mobilization of non-self-transmissible R plasmids. The standard trimethoprim R plasmids were R483, R67 (14) , and pAZI (11) .
Media. Davis-Mingioli (DM) minimal medium (8) was made up as described by Smith (17) Transfer of R plasmids. Overnight cultures of donor and recipient strains grown at 37°C in nutrient broth were mixed in a ratio of 1 to 10 in 4.5 ml of nutrient broth. The mating mixtures were incubated statically at 37°C for 18 h, after which 0.01 ml was streaked onto selection plates as described in Results. When selection was made on DM minimal medium, the mating mixtures were washed and resuspended in DM medium before they were plated out.
Non-self-transmissible plasmids were mobilized with the transfer factor X+. Overnight nutrient broth cultures of E. coli K-12(X+) and the clinical strains were mixed in a ratio of 1 to 10 in 4.5 ml of nutrient broth. After 18 h of incubation at 37°C, 1.0 ml of this mating mixture was mixed with 1.0 ml of an overnight nutrient broth culture of the appropriate J62 recipient strain in 4.5 ml of nutrient broth. After another 18 h of incubation at 37°C, transconjugants were selected as before.
DNA isolation. Plasmid DNA was isolated by the method of Birnboim and Doly (6) . Plasmid sizes were determined in 0.5% agarose 15 Electran (BDH, Poole, United Kingdom) by horizontal gel electrophoresis.
Restriction endonuclease analysis. Plasmid DNA for restriction endonuclease analysis was prepared by the method 62 YOUNG ET AL. (Table  1) . Restriction endonuclease analysis showed that, with only one exception, plasmids with the same resistance pattern gave identical restriction digest patterns (Fig. 1) . Thus, a total of seven different plasmid types were identified.
Determination of the resistance level conferred by unusual trimethoprim R plasmids. Because the transconjugants had been selected for Tpr and they now appeared to be only weakly Tpr on Oxoid DSTA, the MIC of trimethoprim for these strains was determined on a variety of complex media and on suitably supplemented DM minimal agar. The results (Table 2) show that, with only one exception [J62-2(pUK1114)], the MIC of trimethoprim for the J62-2 strains harboring these plasmids was much lower in complex media than any MIC previously described for R-plasmid-mediated Tpr. The level of resistance varied slightly from medium to medium and was not greatly affected by the presence of lysed horse blood. On the other hand, the MIC of trimethoprim for each strain, when tested on suitably supplemented DM minimal agar, was considerably higher (8-to 30-fold) and confirmed that the Tpr determinant had transferred.
The bacterial response to trimethoprim in minimal medium differs, depending on whether methionine, glycine, and a purine derivative are present in the medium (3) . Therefore, the MIC of trimethoprim for each organism was redetermined on suitably supplemented DM agar plates to which methionine, glycine, and adenine had been added, each at a concentration of 50 mg/liter. The results (Table 2) show that the presence of these supplements dramatically reduced the MIC of trimethoprim for each strain to a level similar to that obtained in complex media. The additional presence of uridine, which prevents the uptake of thymine by strains rendered phenotypically thymineless by the presence of trimethoprim (4), had no effect on the MIC of trimethoprim (results not shown).
No significant difference in the MIC of trimethoprim was found for J62-2 strains harboring trimethoprim R plasmids encoding the type I (R483), Il (R67), or III (pAZ1) dihydrofolate reductases when the strains were tested on the various media (Table 2) . DISCUSSION An important observation in this study was that conventional methods for detecting trimethoprim R plasmids may fail with certain plasmids. When Tpr transconjugant strains were selected on complex media (Oxoid DSTA), 42.3% of the resistant isolates tested were shown to possess trimethoprim R plasmids. However, the repetition of transfer experiments and subsequent selection of Tpr transconjugants on suitably supplemented DM minimal medium allowed the detection of another 29 trimethoprim R plasmids. Therefore, if the selection of trimethoprim R plasmids had been made exclusively on complex media, 27% of the transferable trimethoprim R plasmids would have remained undetected, even though low-temperature transfer and mobilization experiments had also been performed. We therefore recommend that minimal medium with defined amino acid supplements be used routinely for plasmid transfer experiments.
Characterization of the R plasmids revealed the existence of 12 Amyes and Smith (3) demonstrated that in minimal medium the bacterial response to trimethoprim is bacteriostatic in the absence of methionine, glycine, and adenine but is bactericidal in their presence. The difference in the MIC of trimethoprim for strains harboring these plasmids suggests that the presence of the metabolites influences the expression of Tpr. This is quite unlike any plasmid-determined Tpr previously described. The trimethoprim R plasmids reported by Towner and Pinn (21) and Fling et al. (10) also confer low levels of Tpr. However, the MICs in these studies were determined in complex media, and these plasmids produced levels of resistance similar to those reported here for DM minimal medium. It seems, therefore, that the resistance mechanism mediated by the plasmids in these previous studies was not unduly depressed by the presence of methionine, glycine, and purines in the media. Indeed, the resistance mechanism of the plasmid described by Fling et al. has since been shown to be due to the plasmid-encoded production of a new dihydrofolate reductase (type III) (11) . We have now shown that the Tpr mechanism of the unusual plasmid pUK1123 described here is due to the plasmid production of yet another dihydrofolate reductase (type IV), the synthesis of which is inducible (21a) .
